EUVIMED · CrossrefZeitschrift
Future HIV Therapy
ISSN 1746-9600 · Informa UK Limited
Neueste Artikel
Introducing Future HIV Therapy
Mucosal Immunopathogenesis of HIV Infection: Implications for Vaccine Development
HIV-1 Assembly and Cellular Trafficking Pathways: Current Understanding and Potential for Future Therapeutics
14th Conference on Retroviruses and Opportunistic Infections (CROI 2007)
Antiretroviral Therapy Among HIV-Infected Breastfeeding Mothers: A Promising Strategy to Prevent HIV Postnatal Transmission in Africa
Nevirapine Prophylaxis for the Prevention of Perinatal HIV and the Impact of Resistance Mutations on Subsequent Therapy
Aids Vaccine Development: Challenges and Opportunities
Toward Functional Eradication of HIV Infection
Postexposure Prophylaxis After Sexual Exposure to HIV
Nanotechnology-Based Delivery Systems in Hiv/Aids Therapy
Future of HIV-1 Therapy: New Drugs, New Targets and New Strategies
Nucleoside and Nucleotide Analogue Reverse Transcriptase Inhibitor Toxicity: How Much Longer Must We Wield the Sword?
Role of Structured Treatment Interruption in HIV Infection
Reaching Undetectable Viral Loads After Initial HIV Treatment
A Step Closer to Home-Based HIV Testing
Development of Resistance After Administration of Single-Dose Nevirapine to Prevent Mother-To-Child Transmission of HIV
HIV Vaccine Effectiveness and the Mucosal Interface
Antiherpetic Therapy for HIV Infection: Linking Prevention and Care
Nonviral Pathway Exploited by HIV in Cell Escape
5th European HIV Drug Resistance Workshop
2nd International Conference on HIV Treatment Adherence
Role of Mouse Apobec3 in the Restriction of Mouse Mammary Tumor Virus Replication In Vivo
The Bull‘S-Eye for HIV Vaccine Development Defined
Exclusive Breastfeeding and HIV-1 Transmission
Microbicides in HIV Prevention
Combined Use of Cytokines, Hormones and Therapeutic Vaccines During Effective Antiretroviral Therapy
Metabolic Complications of HIV Infection and Its Therapy in Children
Molecular Mechanisms of HIV-1 Resistance to Nucleoside and Nucleotide Reverse Transcriptase Inhibitors
Important Considerations Regarding Antiretroviral Therapy in HIV-Positive Women
Treating Pregnant Women with Highly Active Antiretroviral Therapy
EUVIMED